Rhumbline Advisers Organon & Co. Transaction History

Rhumbline Advisers

$103 Billion
Q1 2024

A detailed history of Rhumbline Advisers transactions in Organon & Co. stock. As of the latest transaction made, Rhumbline Advisers holds 544,141 shares of OGN stock, worth $10.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

544,141

Previous 577,437 5.77%

Holding current value

$10.9 Million

Previous $8.33 Million 22.86%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$13.78 - $18.8 $458,818 - $625,964	-33,296 Reduced 5.77%	544,141 $10.2 Million
Q4 2023 Feb 08, 2024	BUY	$10.95 - $17.32 $1.4 Million - $2.22 Million	128,001 Added 28.48%	577,437 $8.33 Million
Q3 2023 Nov 09, 2023	SELL	$16.59 - $23.77 $105,910 - $151,747	-6,384 Reduced 1.4%	449,436 $7.8 Million
Q2 2023 Aug 08, 2023	SELL	$19.27 - $24.63 $107,141 - $136,942	-5,560 Reduced 1.21%	455,820 $9.49 Million
Q1 2023 May 11, 2023	BUY	$21.42 - $32.08 $302,236 - $452,648	14,110 Added 3.15%	461,380 $10.9 Million

Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $386,712 - $474,639	16,590 Added 3.85%	447,270 $12.5 Million
Q3 2022 Nov 10, 2022	BUY	$23.4 - $34.25 $412,776 - $604,170	17,640 Added 4.27%	430,680 $10.1 Million
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $1.38 Million - $1.69 Million	43,573 Added 11.79%	413,040 $13.9 Million
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $626,661 - $810,028	-20,580 Reduced 5.28%	369,467 $12.9 Million
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $252,640 - $327,189	8,812 Added 2.31%	390,047 $11.9 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $105,472 - $131,297	-3,684 Reduced 0.96%	381,235 $12.5 Million
Q2 2021 Aug 05, 2021	BUY	$28.45 - $38.0 $11 Million - $14.6 Million	384,919 New	384,919 $11.6 Million

Others Institutions Holding OGN

# of Institutions

788

Shares Held

190M

Call Options Held

2.46M

Put Options Held

2.27M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $5.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Organon & Co. Transaction History